Next-Generation Imaging

Latest News

Conceptual image for prostate cancer treatment | Image Credit: © Dr_Microbe - stock.adobe.com
PSMA uptake, access appear high for US-based urologists

September 18th 2023

An exclusive Urology Times survey measured US-based urologists’ uptake, access to, and indications for utilizing prostate-specific membrane antigen-targeting agents.

PSMA PET–based model may alleviate diagnostic challenges of ‘PSA gray zone’
PSMA PET–based model may alleviate diagnostic challenges of ‘PSA gray zone’

September 15th 2023

Preliminary results promising for 64Cu SAR-Bombesin in prostate cancer
Preliminary results promising for 64Cu SAR-Bombesin in prostate cancer

September 14th 2023

Guidelines published for 177Lu-PSMA-617  patient selection and use in prostate cancer
Guidelines published for 177Lu-PSMA-617 patient selection and use in prostate cancer

September 6th 2023

First patient dosed at highest level in trial of novel PSMA theranostic in mCRPC
First patient dosed at highest level in trial of novel PSMA theranostic in mCRPC

August 25th 2023

Latest CME Events & Activities

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

Addressing Healthcare Inequities: Overcoming Challenges in the Equitable Management of Idiopathic Pulmonary Fibrosis

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

© 2023 MJH Life Sciences

All rights reserved.